Navigation Links
Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance
Date:1/5/2012

tivity and the company's current dividend.

Webcast of Conference Call

As previously announced, investors, media and the general public can access a live webcast of the 2012 financial guidance conference call through a link on Lilly's website at www.investor.lilly.com. The conference call will be held today beginning at 9:30 a.m. Eastern Standard Time (EST) and will be available for replay via the website through March 2, 2012.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com; Lilly's clinical trial registry is available at www.lillytrials.com.

F-LLY

This press release contains forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. There are significant risks and uncertainties in pharmaceutical research and development. There can be no guarantees with respect to pipeline products that the products will receive the necessary clinical and manufacturing regulatory approvals or that they will prove to be commercially successful. Pharmaceutical products can develop unexpected safety or efficacy concerns. The company's results may also be affected by such factors as competitive developments affecting current products, including the impact of generic competition; market uptake of recently-launched products; the timing of anticipated regulatory approvals and launches of new products; regulatory actions regarding currently marketed
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wmn42n/prescription_pain ) ... Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ Inhaled, ... and Opportunities: 2015 - 2020 Analysis and Forecasts" ... Pain is defined as an unpleasant sensory and ... damage. At some point, everyone experiences pain. Pain ...
(Date:8/30/2015)... 2015 La solución de ... cuidado al paciente a lo ... Royal Philips  (NYSE: PHG, AEX: PHIA) ... Cardiovascular , un sistema web de gestión de imágenes ... y compartir imágenes cardiovasculares e información en cualquier momento, ...
(Date:8/28/2015)...  With the heroin epidemic in the ... Jacksonville -based Lakeview Health drug and alcohol treatment ... explain why fentanyl is causing a new wave of ... more potent than pharmaceutical grade heroin and often illegally ... of death skyrockets. "Fentanyl can be an ...
Breaking Medicine Technology:Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
...  NxStage Medical, Inc. (Nasdaq: NXTM ), a ... to release its financial results for the fourth quarter ... February 29, 2012  before the opening of the financial ... NxStage will also host a conference call at ...
... (OTC BB: IVOB), a medical device company focused on ... that the National Health Surveillance Agency (ANVISA) in Brazil ... a Class II device. This approval allows the INVOcell ... Brazil and marks a major milestone in the history ...
Cached Medicine Technology:NxStage® to Report Fourth Quarter and Full Year 2011 Financial Results 2INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA 2INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA 3
(Date:8/31/2015)... KY (PRWEB) , ... August 31, 2015 , ... ... Wyoming, has selected ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation Improvement ... engine, ezNLP, and a patent pending ICD-10 solution - ezCAC is an enterprise-level ...
(Date:8/31/2015)... ... 2015 , ... Castle Dermatology Institute now welcomes San Fernando Valley skin ... of the University of California, Los Angeles. He graduated summa cum laude with a ... Irvine Medical School. As a nationally recognized Regents Scholar, Dr. Ghasri was given numerous ...
(Date:8/31/2015)... ... ... “My mother and husband use oxygen therapy and the tubing irritates the ... be a comfortable way to prevent the irritation, so I invented this.” She invented ... secure way to anchor the cannula tubing used in oxygen therapy and it prevents ...
(Date:8/31/2015)... ... ... A year ago this month, Seniors Guide first hit stands in the Columbus, ... successful first year. , “We started the magazine with the goal of giving ... says Melissa Wolfert, founding Publisher for Seniors Guide Columbus. “Making the decision to move ...
(Date:8/31/2015)... ... 2015 , ... There’s big news for ZendyHealth , a Los Angeles-based ... Consumer driven health plans (CDHPs) are a growing phenomenon, and ZendyHealth has brought on ... company, and another to answer customers’ questions directly. , John Young, CEO of Consumerdriven, ...
Breaking Medicine News(10 mins):Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3
... skin appendages such as hair, nails, sweat glands and ... in the United States, according to a report in ... one of the JAMA/Archives journals. "Cutaneous appendageal carcinomas ... with diverse differentiation that frequently present a diagnostic challenge," ...
... illess, they don,t heed the dangers, survey finds , ... the chances of developing heat illness, many people with ... a new Mayo Clinic survey reveals. , , "People ... predisposes them to heat-related illness, as do uncontrolled high ...
... at loud volume may lead to temporary and later irreversible ... People using MP3 players are leaving themselves open to temporary ... hearing loss, Belgian researchers suggest. , Scientists already know that ... too loud or loud sounds that go on too long ...
... A recent study of an ancient language provides ... potential applications for today,s world. The study, "Dvandvas, Blocking, ... Word," to be published in the June 2010 issue ... by Paul Kiparsky of Stanford University. A preprint version ...
... suicide are more likely to use violent means (such as ... overdose), new research suggests. In a study of more ... researchers found that, despite having access to potentially lethal substances, ... The study was reported in the July issue of the ...
... least 4 to 6 months of exclusive breast-feeding best, ... seems to provide an immune system boost to infants, ... according to new research. , Babies who were breast-fed ... were 6 months old, had a reduced risk of ...
Cached Medicine News:Health News:Cancers of sweat glands, other skin-related structures may be increasing in United States 2Health News:Many Diabetics Unaware of Hot Weather Hazards 2Health News:MP3 Players Might Harm Hearing 2Health News:MP3 Players Might Harm Hearing 3Health News:The 'bumpy ride' of linguistic change 2Health News:Violence, not overdose, the likely method of suicide in veterans with substance use disorders 2Health News:Breast Milk Reduces Infections in Babies 2Health News:Breast Milk Reduces Infections in Babies 3
Corneal Marking Pen - Sterile. 10 pieces/box...
Coronet Donor Punch Set - Unique design providing precise control and full visualization throughout the procedure. Corneal marking pen included....
... new generation in automated semen analysis, with ... of a button. Automation provides standardization and ... out of semen analysis. SPERMALITE is a ... for remote semen analysis, and a hard ...
... LactoSorb copolymer maintains almost all its ... complete mass loss in 915 months. Blunt ... Seventeen sizes to maximize surgeons options. ... the entire screw to help prevent the ...
Medicine Products: